Utility Assessment in Cancer Patients: Adjustment of Time Tradeoff Scores for the Utility of Life Years and Comparison with Standard Gamble Scores

The standard gamble (SG) and the time tradeoff (TTO), two frequently used methods of utility assessment, have often been found to lead to different utilities for the same health state. The authors investigated whether adjustment of TTO scores for the utility of life years (risk attitude) eliminated...

Full description

Saved in:
Bibliographic Details
Published in:Medical decision making 1994, Vol.14 (1), p.82-90
Main Authors: Stiggelbout, A.M., Kiebert, G.M., Kievit, J., Leer, J.W.H., Stoter, G., De Haes, J.C.J.M.
Format: Article
Language:English
Subjects:
Adult
Chemotherapy, Adjuvant
Combined Modality Therapy
Decision Support Techniques
Humans
Male
Middle Aged
Neoplasms - mortality
Neoplasms - therapy
Neoplasms, Germ Cell and Embryonal - mortality
Neoplasms, Germ Cell and Embryonal - therapy
Orchiectomy
Prognosis
Quality of Life
Risk
Survival Analysis
Testicular Neoplasms - mortality
Testicular Neoplasms - therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c233t-ceb4df5ba9effe5e11bfdda9358b423c3e67231bedb931efb1b7b58530713a603
container_end_page 90
container_issue 1
container_start_page 82
container_title Medical decision making
container_volume 14
creator Stiggelbout, A.M.
Kiebert, G.M.
Kievit, J.
Leer, J.W.H.
Stoter, G.
De Haes, J.C.J.M.
description The standard gamble (SG) and the time tradeoff (TTO), two frequently used methods of utility assessment, have often been found to lead to different utilities for the same health state. The authors investigated whether adjustment of TTO scores for the utility of life years (risk attitude) eliminated this difference. In addition, the association between risk attitude and sociodemographic and medical variables was studied. In 30 disease-free testicular cancer patients, SG and TTO were used to assess the utilities of four health profiles relevant to testicular cancer. Utility of life years was estimated from certainty equivalents (CEs). SG scores were significantly higher than unadjusted TTO scores for all profiles. As the majority of patients (85%) were risk-averse, CE-adjusted TTO scores were higher than unadjusted scores, and were not significantly different from those obtained from the SG for three of the four profiles. However, adjusted scores were still slightly but consistently lower than SG scores. Possible explanations for this discrepancy are discussed. An association was found between risk aversion and medical treatment: patients who had received chemotherapy for their cancers were more risk-averse than were patients who had been in a surveillance protocol only. As risk aversion can have an impact on treatment decisions, it is important to assess the risk posture of the patient to whom the decision pertains. Key words: utility assessment; QALY; risk aversion; oncology; treatment preferences. (Med Decis Making 1994;14:82-90)
doi_str_mv 10.1177/0272989X9401400110
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76436878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0272989X9401400110</sage_id><sourcerecordid>76436878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c233t-ceb4df5ba9effe5e11bfdda9358b423c3e67231bedb931efb1b7b58530713a603</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotVb_gCDMRndjc_OYZJal-IKCLix0F5KZG5kyj5rMLPrvndLiRnB14ZzvHLiHkFugjwBKzSlTLNf5JhcUBKUA9IxMQUqWZho252R6ANIDcUmuYtyOiMi1mJCJBsl4Rqfkft1XddXvk0WMGGODbZ9UbbK0bYEh-bB9NSrxmlx4W0e8Od0ZWT8_fS5f09X7y9tysUoLxnmfFuhE6aWzOXqPEgGcL0ubc6mdYLzgmCnGwWHpcg7oHTjlpJacKuA2o3xGHo69u9B9Dxh701SxwLq2LXZDNCoTPNNKjyA7gkXoYgzozS5UjQ17A9QctjF_txlDd6f2wTVY_kZOY4z-_OhH-4Vm2w2hHZ_9r_EH4Pxr_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76436878</pqid></control><display><type>article</type><title>Utility Assessment in Cancer Patients: Adjustment of Time Tradeoff Scores for the Utility of Life Years and Comparison with Standard Gamble Scores</title><source>SAGE Complete Deep Backfile Purchase 2012</source><creator>Stiggelbout, A.M. ; Kiebert, G.M. ; Kievit, J. ; Leer, J.W.H. ; Stoter, G. ; De Haes, J.C.J.M.</creator><creatorcontrib>Stiggelbout, A.M. ; Kiebert, G.M. ; Kievit, J. ; Leer, J.W.H. ; Stoter, G. ; De Haes, J.C.J.M.</creatorcontrib><description>The standard gamble (SG) and the time tradeoff (TTO), two frequently used methods of utility assessment, have often been found to lead to different utilities for the same health state. The authors investigated whether adjustment of TTO scores for the utility of life years (risk attitude) eliminated this difference. In addition, the association between risk attitude and sociodemographic and medical variables was studied. In 30 disease-free testicular cancer patients, SG and TTO were used to assess the utilities of four health profiles relevant to testicular cancer. Utility of life years was estimated from certainty equivalents (CEs). SG scores were significantly higher than unadjusted TTO scores for all profiles. As the majority of patients (85%) were risk-averse, CE-adjusted TTO scores were higher than unadjusted scores, and were not significantly different from those obtained from the SG for three of the four profiles. However, adjusted scores were still slightly but consistently lower than SG scores. Possible explanations for this discrepancy are discussed. An association was found between risk aversion and medical treatment: patients who had received chemotherapy for their cancers were more risk-averse than were patients who had been in a surveillance protocol only. As risk aversion can have an impact on treatment decisions, it is important to assess the risk posture of the patient to whom the decision pertains. Key words: utility assessment; QALY; risk aversion; oncology; treatment preferences. (Med Decis Making 1994;14:82-90)</description><identifier>ISSN: 0272-989X</identifier><identifier>EISSN: 1552-681X</identifier><identifier>DOI: 10.1177/0272989X9401400110</identifier><identifier>PMID: 8152360</identifier><language>eng</language><publisher>Thousand Oaks, CA: Sage Publications</publisher><subject>Adult ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Decision Support Techniques ; Humans ; Male ; Middle Aged ; Neoplasms - mortality ; Neoplasms - therapy ; Neoplasms, Germ Cell and Embryonal - mortality ; Neoplasms, Germ Cell and Embryonal - therapy ; Orchiectomy ; Prognosis ; Quality of Life ; Risk ; Survival Analysis ; Testicular Neoplasms - mortality ; Testicular Neoplasms - therapy</subject><ispartof>Medical decision making, 1994, Vol.14 (1), p.82-90</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c233t-ceb4df5ba9effe5e11bfdda9358b423c3e67231bedb931efb1b7b58530713a603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0272989X9401400110$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0272989X9401400110$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>315,786,790,4043,21873,27956,27957,27958,45117,45505</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8152360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stiggelbout, A.M.</creatorcontrib><creatorcontrib>Kiebert, G.M.</creatorcontrib><creatorcontrib>Kievit, J.</creatorcontrib><creatorcontrib>Leer, J.W.H.</creatorcontrib><creatorcontrib>Stoter, G.</creatorcontrib><creatorcontrib>De Haes, J.C.J.M.</creatorcontrib><title>Utility Assessment in Cancer Patients: Adjustment of Time Tradeoff Scores for the Utility of Life Years and Comparison with Standard Gamble Scores</title><title>Medical decision making</title><addtitle>Med Decis Making</addtitle><description>The standard gamble (SG) and the time tradeoff (TTO), two frequently used methods of utility assessment, have often been found to lead to different utilities for the same health state. The authors investigated whether adjustment of TTO scores for the utility of life years (risk attitude) eliminated this difference. In addition, the association between risk attitude and sociodemographic and medical variables was studied. In 30 disease-free testicular cancer patients, SG and TTO were used to assess the utilities of four health profiles relevant to testicular cancer. Utility of life years was estimated from certainty equivalents (CEs). SG scores were significantly higher than unadjusted TTO scores for all profiles. As the majority of patients (85%) were risk-averse, CE-adjusted TTO scores were higher than unadjusted scores, and were not significantly different from those obtained from the SG for three of the four profiles. However, adjusted scores were still slightly but consistently lower than SG scores. Possible explanations for this discrepancy are discussed. An association was found between risk aversion and medical treatment: patients who had received chemotherapy for their cancers were more risk-averse than were patients who had been in a surveillance protocol only. As risk aversion can have an impact on treatment decisions, it is important to assess the risk posture of the patient to whom the decision pertains. Key words: utility assessment; QALY; risk aversion; oncology; treatment preferences. (Med Decis Making 1994;14:82-90)</description><subject>Adult</subject><subject>Chemotherapy, Adjuvant</subject><subject>Combined Modality Therapy</subject><subject>Decision Support Techniques</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasms - mortality</subject><subject>Neoplasms - therapy</subject><subject>Neoplasms, Germ Cell and Embryonal - mortality</subject><subject>Neoplasms, Germ Cell and Embryonal - therapy</subject><subject>Orchiectomy</subject><subject>Prognosis</subject><subject>Quality of Life</subject><subject>Risk</subject><subject>Survival Analysis</subject><subject>Testicular Neoplasms - mortality</subject><subject>Testicular Neoplasms - therapy</subject><issn>0272-989X</issn><issn>1552-681X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLAzEUhYMotVb_gCDMRndjc_OYZJal-IKCLix0F5KZG5kyj5rMLPrvndLiRnB14ZzvHLiHkFugjwBKzSlTLNf5JhcUBKUA9IxMQUqWZho252R6ANIDcUmuYtyOiMi1mJCJBsl4Rqfkft1XddXvk0WMGGODbZ9UbbK0bYEh-bB9NSrxmlx4W0e8Od0ZWT8_fS5f09X7y9tysUoLxnmfFuhE6aWzOXqPEgGcL0ubc6mdYLzgmCnGwWHpcg7oHTjlpJacKuA2o3xGHo69u9B9Dxh701SxwLq2LXZDNCoTPNNKjyA7gkXoYgzozS5UjQ17A9QctjF_txlDd6f2wTVY_kZOY4z-_OhH-4Vm2w2hHZ_9r_EH4Pxr_Q</recordid><startdate>1994</startdate><enddate>1994</enddate><creator>Stiggelbout, A.M.</creator><creator>Kiebert, G.M.</creator><creator>Kievit, J.</creator><creator>Leer, J.W.H.</creator><creator>Stoter, G.</creator><creator>De Haes, J.C.J.M.</creator><general>Sage Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1994</creationdate><title>Utility Assessment in Cancer Patients</title><author>Stiggelbout, A.M. ; Kiebert, G.M. ; Kievit, J. ; Leer, J.W.H. ; Stoter, G. ; De Haes, J.C.J.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c233t-ceb4df5ba9effe5e11bfdda9358b423c3e67231bedb931efb1b7b58530713a603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Chemotherapy, Adjuvant</topic><topic>Combined Modality Therapy</topic><topic>Decision Support Techniques</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasms - mortality</topic><topic>Neoplasms - therapy</topic><topic>Neoplasms, Germ Cell and Embryonal - mortality</topic><topic>Neoplasms, Germ Cell and Embryonal - therapy</topic><topic>Orchiectomy</topic><topic>Prognosis</topic><topic>Quality of Life</topic><topic>Risk</topic><topic>Survival Analysis</topic><topic>Testicular Neoplasms - mortality</topic><topic>Testicular Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stiggelbout, A.M.</creatorcontrib><creatorcontrib>Kiebert, G.M.</creatorcontrib><creatorcontrib>Kievit, J.</creatorcontrib><creatorcontrib>Leer, J.W.H.</creatorcontrib><creatorcontrib>Stoter, G.</creatorcontrib><creatorcontrib>De Haes, J.C.J.M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical decision making</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stiggelbout, A.M.</au><au>Kiebert, G.M.</au><au>Kievit, J.</au><au>Leer, J.W.H.</au><au>Stoter, G.</au><au>De Haes, J.C.J.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility Assessment in Cancer Patients: Adjustment of Time Tradeoff Scores for the Utility of Life Years and Comparison with Standard Gamble Scores</atitle><jtitle>Medical decision making</jtitle><addtitle>Med Decis Making</addtitle><date>1994</date><risdate>1994</risdate><volume>14</volume><issue>1</issue><spage>82</spage><epage>90</epage><pages>82-90</pages><issn>0272-989X</issn><eissn>1552-681X</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>The standard gamble (SG) and the time tradeoff (TTO), two frequently used methods of utility assessment, have often been found to lead to different utilities for the same health state. The authors investigated whether adjustment of TTO scores for the utility of life years (risk attitude) eliminated this difference. In addition, the association between risk attitude and sociodemographic and medical variables was studied. In 30 disease-free testicular cancer patients, SG and TTO were used to assess the utilities of four health profiles relevant to testicular cancer. Utility of life years was estimated from certainty equivalents (CEs). SG scores were significantly higher than unadjusted TTO scores for all profiles. As the majority of patients (85%) were risk-averse, CE-adjusted TTO scores were higher than unadjusted scores, and were not significantly different from those obtained from the SG for three of the four profiles. However, adjusted scores were still slightly but consistently lower than SG scores. Possible explanations for this discrepancy are discussed. An association was found between risk aversion and medical treatment: patients who had received chemotherapy for their cancers were more risk-averse than were patients who had been in a surveillance protocol only. As risk aversion can have an impact on treatment decisions, it is important to assess the risk posture of the patient to whom the decision pertains. Key words: utility assessment; QALY; risk aversion; oncology; treatment preferences. (Med Decis Making 1994;14:82-90)</abstract><cop>Thousand Oaks, CA</cop><pub>Sage Publications</pub><pmid>8152360</pmid><doi>10.1177/0272989X9401400110</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-989X
ispartof Medical decision making, 1994, Vol.14 (1), p.82-90
issn 0272-989X
1552-681X
language eng
recordid cdi_proquest_miscellaneous_76436878
source SAGE Complete Deep Backfile Purchase 2012
subjects Adult
Chemotherapy, Adjuvant
Combined Modality Therapy
Decision Support Techniques
Humans
Male
Middle Aged
Neoplasms - mortality
Neoplasms - therapy
Neoplasms, Germ Cell and Embryonal - mortality
Neoplasms, Germ Cell and Embryonal - therapy
Orchiectomy
Prognosis
Quality of Life
Risk
Survival Analysis
Testicular Neoplasms - mortality
Testicular Neoplasms - therapy
title Utility Assessment in Cancer Patients: Adjustment of Time Tradeoff Scores for the Utility of Life Years and Comparison with Standard Gamble Scores
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T17%3A14%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20Assessment%20in%20Cancer%20Patients:%20Adjustment%20of%20Time%20Tradeoff%20Scores%20for%20the%20Utility%20of%20Life%20Years%20and%20Comparison%20with%20Standard%20Gamble%20Scores&rft.jtitle=Medical%20decision%20making&rft.au=Stiggelbout,%20A.M.&rft.date=1994&rft.volume=14&rft.issue=1&rft.spage=82&rft.epage=90&rft.pages=82-90&rft.issn=0272-989X&rft.eissn=1552-681X&rft_id=info:doi/10.1177/0272989X9401400110&rft_dat=%3Cproquest_cross%3E76436878%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c233t-ceb4df5ba9effe5e11bfdda9358b423c3e67231bedb931efb1b7b58530713a603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76436878&rft_id=info:pmid/8152360&rft_sage_id=10.1177_0272989X9401400110&rfr_iscdi=true